Proactive Investors - Contract research specialist hVIVO PLC said it has signed a US$5.2mln contract with a biotech company in the Asia Pacific region to test the latter's...
A recent capital markets day spelt out why hVIVO is so structurally well-positioned as the world-leading provider of challenge studies, according to broker Liberum. In particular,...
By Kate Kelland LONDON (Reuters) - "Human challenge" trials of potential COVID-19 vaccines, where volunteers are deliberately infected with the disease, could become a reality...
hVIVO plc, formerly Open Orphan plc, is a United Kingdom-based specialist contract research organization (CRO). The Company is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. It provides end-to-end early clinical development services to its client base, which includes global biopharma companies. It offers a portfolio of approximately 10+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. It offers additional clinical field trial services, such as patient recruitment and clinical trial site services. It runs challenge studies in from its Whitechapel quarantine clinic, and its QMB clinic with its specialized on-site virology and immunology laboratory.
| Average | 0.38 (-97.68% Downside) |
| High | 0.5433 |
| Low | 0.2836 |
| Price | 16.30 |
| No. of Analysts | 4 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Neutral | Buy | Strong Buy |
| Technical Indicators | Buy | Sell | Strong Sell | Strong Buy | Neutral |
| Summary | Neutral | Sell | Sell | Strong Buy | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 151.20 | 152.40 | 147.80 | 0.00 | 0.00% | 0.00 | London | |||
| 363.41 | 363.41 | 363.41 | -3.19 | -0.87% | 4.25K | London | |||
| 105.69 | 107.00 | 107.00 | +1.00 | +0.95% | 7.95K | London | |||
| 86.50 | 86.50 | 86.50 | 0.00 | 0.00% | 0.00 | London | |||
| 796.00 | 800.50 | 796.00 | -6.00 | -0.75% | 44.44K | London | |||
| 161.10 | 161.00 | 161.00 | -1.20 | -0.74% | 75.28K | London | |||
| 5.25 | 5.92 | 5.92 | 0.00 | 0.00% | 0.00 | London | |||
| 1,148.00 | 1,149.50 | 1,145.00 | -1.50 | -0.13% | 1.43K | London | |||
| 2,848.00 | 2,856.00 | 2,846.00 | -20.0 | -0.70% | 6.30K | London | |||
| 308.10 | 309.80 | 306.50 | -1.90 | -0.61% | 459.04K | London | |||
| 774.80 | 774.80 | 765.20 | +2.00 | +0.26% | 806.00 | London | |||
| 248.00 | 248.60 | 245.40 | +2.40 | +0.98% | 2.76K | London | |||
| 205.00 | 209.00 | 203.00 | 0.00 | 0.00% | 0.00 | London | |||
| 1,353.49 | 1,346.00 | 1,346.00 | -10.00 | -0.74% | 3.58K | London | |||
| 1,741.00 | 1,745.00 | 1,739.50 | -13.00 | -0.74% | 21.69K | London |